期刊文献+

大数据的现状、机遇与挑战 被引量:3

Big data of current state, opportunity and challenge
原文传递
导出
摘要 大数据的数据量非常巨大,以至传统数据储存和计算等技术无法有效地进行数据处理,且产生和变化的速度快、种类繁杂,数据的真实性也有很大的不确定性。在医疗数字化的过程中,医院成了大数据产生的重要来源,病历、影像、远程医疗等都会产生大量的数据。对医疗卫生行业而言,大数据正在传统的商业智能和临床决策支持系统的基础上,延伸至人们将医疗网络产生的大数据应用到循证医疗中,从而助力精准医疗、健康管理和智慧医疗,甚至生物样本库的建立和应用中。本文主要阐述现阶段大数据的组成与特征,大数据分析处理的框架和方法,同时分析医疗大数据的发展机遇和应用中面临的挑战。 Big data refers to the data sets that have become so large and/or complex that traditional data technology is inadequate to process them effectively. Big data has large volume; changes quickly; has great variety; and has a good deal of uncertainty in its veracity. During the digitization of healthcare, hospitals become important sources of big data. Large volume of data is created from medical records, medical images, and distance medicine. For healthcare industry, big data analytics are evolving beyond traditional business intelligence and clinical decision support systems. It utilizes the vast amount of data gathered from healthcare networks for evidence-based medicine, propels precision medicine, health management, disease prevention, even the establishment and application of biobanks. This paper summarizes the current composition, characteristics, and trend of big data. It introduces the framework, tools, and methods for big data analytics.
作者 汪浩
出处 《中华临床实验室管理电子杂志》 2017年第1期30-35,共6页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
关键词 大数据分析 大数据管理 精准医疗 疾病预防 Big data analytics Big data management Precision medicine Disease prevention
  • 相关文献

参考文献1

二级参考文献16

  • 1National Institutes of Health, National Cancer Institute. PDQCervical Cancer Prevention: Date last modified.2016. Bethesda, MD: National Cancer Institute. http://www.cancer.gov/types/cervical/hp/ cervical-treatment-pdq.
  • 2Cervical Cancer Screening with HPV Test. http://www2c.cdc.gov/ podcasts/mediaJpdf/Massad%2001 .pdf.
  • 3Zheng B, Li Z, Liang X, et al. Cervical Cytology Reporting Rates from China's Largest College of American Pathologists-Certified Laboratory with a Focus on Squamous Cell Carcinoma Cytology and Its Histopathological Follow-Up Results[J]. Acta Cytolog, 2015,59(5):399-404.
  • 4Zheng B, Austin RM, Liang X, et al. PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory[J]. J Am Soc Cytopathol, 2015,4(2): 84-89.
  • 5Zheng B, Austin RM, Liang X, et al. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory analysis of 1394389 Papanicolaou Test Reports[J]. Arch Pathol Lab Med, 2015,139(3):373-377.
  • 6Zeng Z, Austin RM, He X, et al. Prevalence of High-Risk Human Papillomavirus Infection in China: Analysis of 671,163 Human Papillomavirus Test Results From China's Largest College of American Pathologists-Certified Laboratory[J]. Am J Clin Pathol, 2016,145(5): 622-625.
  • 7Zeng Z, Yang H, Li Z, et al. Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345 HPV Ggenotyping Results from China's Largest CAP Certified Laboratory[J]. J Cancer 2016,7(9): 1037-1043.
  • 8Zheng B, Li Z, Griffith CC, et al. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified Laboratory[J]. Cancer Cytopathol, 2015,123(7):428-434.
  • 9Cervical Cancer Screening (PDQ)-Health Professional Version [DB/OL]. [ 2015-10-07].http://www.cancer.gov/types/cervical/hp/ cervical- screening-pdq.
  • 10Zheng B, Austin M, Liang X, et al. Conventional Pap Smear Cervical Screening in 11 Rural Counties in Hainan Providence, China: Analysis of TBS Reporting Rates For 218,195 Screened Women. The American Society for Colposcopy and Cervical Pathology(ASCCP) meeting, New Orleans: 2016.

共引文献9

同被引文献6

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部